COIN — Coinbase Global, Inc.

As of 2026-09-13 the tape is split. Bears point to the Q2 2026 print filed 2026-07-30: revenue of $1.22B missed ~$1.3B consensus and net income was -$359.5M (diluted EPS -$1.36), with TTM EPS of -$3.75 and a -47.5x P/E that makes the stock un-analyzable on earnings; COIN is 56% off its $402.16 52-week high and 8.4% below its 200-day average. Bulls point to record 10.3% crypto trading market share (third straight quarter of gains), a 14th consecutive quarter of positive Adjusted EBITDA, paid Coinbase One subscribers crossing 1 million, prediction-market contracts +106% QoQ, and an analyst consensus 'Buy' with a $206.15 average target (23 analysts: 21 buy, 13 hold, 4 sell) versus a $175.26 price. The stock is +17.59% over the month to 2026-09-13 but -5.08% over the last week and -10.37% over six months, with RSI at 51.56 - i.e. no one is winning the argument, which is exactly what neutral sentiment looks like.

Three-year revenue shows textbook crypto cyclicality, not a straight line: $674M (Q3 2023) -> $2,272M (Q4 2024, the cycle peak, +88% QoQ) -> $1,032M (Q4 2025, the trough) -> $1,413M (Q1 2026) -> $1,220M (Q2 2026). Full-year revenue was essentially flat at $6.56B in 2024 and $6.43B in 2025, but YoY has turned sharply negative on the last three prints: -54.6% in Q4 2025, -30.5% in Q1 2026 and -18.5% in Q2 2026. The important nuance is that the YoY collapse is a comparison against the Q4 2024-Q1 2025 peak rather than pure deterioration - sequentially, revenue has improved off the $1,032M Q4 2025 trough. Margins show extreme operating leverage: gross margin was 84.4% in Q2 2026 versus 69.7% in Q1 2026, and R&D of $430.6M was 23.0% of revenue in the strong Q3 2025 quarter but $497.3M was 48.2% of revenue in the weak Q4 2025 quarter - the cost base is largely fixed, so trough revenue crushes margins (Q4 2025 operating margin -43%, Q2 2026 -6.0%) and recovery quarters print huge (Q1 2025 +34.7%, Q3 2025 +25.7%). Reported net income is even noisier than operations because of non-operating marks: Q2 2025 had a -$24.7M operating loss but +$1,429M of net income, and Q1 2026 had +$13.7M of operating income but a -$394.1M net loss. Read plainly: this is a cyclical bottoming process with structurally growing revenue diversification underneath it, not a business in structural decline - but the trough is not yet confirmed by the numbers.

On earnings, valuation is uninformative: TTM EPS of -$3.75 makes the -47.5x P/E and 0.358 PEG meaningless, and next-FY consensus EPS is also negative (-$3.00). On sales, COIN is not actually cheap versus its own history despite the score's 'Cheap vs. its own history' overlay: at $175.26 the market cap of $46.2B is 8.36x TTM revenue of $5.53B versus a 5-year average P/S of 7.78x, and roughly 8.9x if you use the $5.19B next-FY consensus revenue. P/B of 3.53x against $13.08B of book equity is the one genuinely undemanding number, and gross margin of 79% with ROIC of 5.2% and ROE of 8.5% shows the asset-light economics that justify a premium multiple in a normal cycle. Verdict as of 2026-09-13: full-but-not-egregious. You are paying an above-average sales multiple for a company with contracting revenue and negative GAAP earnings; the offset is record market share, $8.89B of cash and diversification (subscriptions, stablecoin economics, Base, derivatives) that consensus may be underwriting too pessimistically.

There are no earnings to price against, so the market is pricing an option: TTM EPS -$3.75, next-FY consensus EPS -$3.00 and next-FY consensus revenue of $5.19B (below TTM revenue), yet the stock still carries 8.4x sales. That means the $175.26 price embeds a cycle turn that has not yet shown up in reported numbers - the stock is discounting a recovery in spot volumes plus the 'Everything Exchange' mix (10.3% share, 1M+ Coinbase One subs, prediction markets +106% QoQ, Base network activity) rather than current profitability. Practical read: if Q3 2026 (late Oct/early Nov 2026) shows subscription/derivatives/stablecoin revenue offsetting stagnant spot volume and Adjusted EBITDA stays positive, the $206-$218 sell-side targets become credible and the stock can re-rate; if revenue prints below ~$1.1B with another GAAP loss and no regulatory progress from the mid-September CLARITY Act vote, there is no earnings floor and the stock retests the $139.11 52-week low. The balance sheet ($8.89B cash, $13.08B equity, current ratio 1.54) is the only hard floor.

As of 2026-09-13, COIN's RSI(14) was 51.56 - dead neutral, no oversold entry edge and no overbought exhaustion signal. Price was fractionally above its 20-day average (+0.13%) and 6.19% above its 50-day average (~$165), but still 8.37% below its 200-day average (~$191), so the short-term trend has repaired while the longer-term trend remains down. Momentum is conflicting: +17.59% over the past month versus -5.08% over the past week and -10.37% over six months, inside a $139.11-$402.16 52-week range. Practical implication: this is a range-bound, base-building tape where the 200-day (~$191) is the line in the sand - a decisive reclaim would confirm the bottoming thesis, while a failed retest and loss of the 50-day (~$165) reopens the $139 low. With a binary Senate vote in mid-September 2026, a ~$3.39 beta and 56% peak-to-trough drawdowns, this is a position-size problem more than an entry-timing one.

• Regulation: the mid-September 2026 Senate vote on the Digital Asset Market Clarity Act, which would split market-structure oversight between the SEC and CFTC, is the single largest binary headline for COIN; management claims federal agencies will issue operational crypto rules regardless, but the vote outcome (or failure) will move the stock hard.
• Crypto asset prices and retail trading volumes: COIN revenue is still trading-fee-linked, so flat spot volumes explain the $1.03B to $1.22B quarterly revenue base versus $2.27B at the Q4 2024 peak - a sustained volume recovery is the biggest positive macro lever.
• Interest rates and interest income: Coinbase earns meaningful revenue on cash ($8.89B) and stablecoin reserves; a falling-rate path compresses that revenue line, while rate cuts may simultaneously reflate crypto risk appetite.
• Stablecoin and payment-rail economics (USDC revenue-sharing, Base L2, agentic payments): the growth engine the bull case depends on, but it is sensitive to stablecoin legislation, yield-sharing litigation risk, and Circle's economics.
• Macro risk appetite and high-beta factor exposure: beta of 3.39 means COIN trades as a levered proxy on liquidity conditions and institutional crypto adoption; Fed policy shifts and ETF/ institutional flows amplify moves in both directions.
• Political/ethics scrutiny: disclosure that National Economic Council Director Kevin Hassett held $1M-$5M of Coinbase stock through late 2025 keeps an intermittent headline risk on the name.

• Mid-September 2026 Senate vote on the CLARITY Act - a pass or a credible path to agency rulemaking is a potential re-rating event; a failed vote or indefinite delay extends the regulatory overhang.
• Q3 2026 earnings (expected late Oct/early Nov 2026): the first real test of whether subscription, stablecoin, derivatives (prediction markets +106% QoQ) and Base network revenue can offset spot-volume stagnation while holding Adjusted EBITDA positive for a 15th straight quarter.
• Continued share capture: market share hit a record 10.3% in Q2 2026, a third consecutive quarter of gains, which converts directly into revenue leverage when volumes return.
• Coinbase One subscriber growth past 1 million and 'Everything Exchange' product expansion (derivatives, prediction markets, agentic payments on Base) as new non-trading revenue streams.
• Capital return or opportunistic action with $8.89B of cash against a stock trading near the low end of its 52-week range, plus the possibility that crypto prices and volumes simply mean-revert higher.

• Deepening crypto bear market: another leg down in spot volumes could push quarterly revenue below $1.0B, where the ~$473-526M/quarter R&D run-rate is 40%+ of revenue and GAAP operating losses widen materially.
• Persistent GAAP losses and the non-operating marks that drive them - Q1 2026 (-$394M) and Q2 2026 (-$359M) losses were not fully explained by operating performance, and the same mechanism cuts both ways (Q2 2025 net income of +$1,429M came on a -$24.7M operating loss).
• Regulatory binary risk: the CLARITY Act failing, or an adverse SEC/CFTC rulemaking or enforcement action, could hit listing, staking, stablecoin and derivatives revenue simultaneously.
• Competition and fee compression: Binance, Kraken, Robinhood, CME in derivatives, and direct stablecoin issuers all pressure take rates even as COIN gains share of a shrinking pie.
• Balance-sheet risk: long-term debt jumped from $2.97B at 2025-06-30 to $5.94B at 2025-09-30 (~$3B raised), and stockholders' equity fell from $14.79B (2025-12-31) to $13.08B (2026-06-30) - leverage into a cyclical trough is a real constraint if losses continue.
• Valuation risk: 8.36x TTM sales (above the 7.78x five-year average) on a business with negative next-FY consensus EPS leaves little margin for error if the recovery is delayed a few quarters.

Coinbase is the highest-quality way to own regulated crypto infrastructure at a cyclical low point, but as of 2026-09-13 the price already reflects much of that hope. The good part is real and improving: record 10.3% market share, 14 straight quarters of positive Adjusted EBITDA, 79% gross margin, healthy accruals (-2.1%, meaning cash flow exceeds reported income), $8.89B of cash and revenue diversifying away from BTC spot. The bad part is equally real: three straight quarters of negative YoY revenue growth, TTM EPS of -$3.75, next-FY consensus EPS of -$3.00 on revenue that consensus expects to shrink, and 8.4x sales that sits above the stock's own five-year average. My own fair value works out to roughly $188, only ~7% above the $175.26 price, so this is a fairly-valued cyclical, not a bargain. I would not chase the mid-September regulatory vote, and I would want either a confirmed volume-based revenue recovery in Q3 2026 or an entry closer to the $139-$150 low end of the 52-week range before treating COIN as an asymmetric buy.

I used a normalized revenue multiple plus net cash rather than a P/E, since TTM EPS (-$3.75) and next-FY consensus EPS (-$3.00) are both negative. Inputs: normalized annual net revenue of $6.2B (between the $6.56B reported in 2024, $6.43B in 2025 and the $5.53B TTM trough, deliberately above the $5.19B next-FY consensus which assumes spot volumes stay stagnant); a 7.5x P/S multiple, slightly below the stock's own 7.78x five-year average and justified by 79% gross margin and record market share but discounted for cyclicality and negative GAAP earnings; that yields a $46.5B operating value, plus ~$2.95B of net cash ($8.89B cash less $5.94B long-term debt), giving ~$49.5B of equity value across ~264M diluted shares (from the $46.24B market cap / $175.26 price) = approximately $188 per share.